In the BioHarmony Drug Report Database

"Preview" Icon

Naratriptan

Amerge (naratriptan) is a small molecule pharmaceutical. Naratriptan was first approved as Amerge on 1998-02-10. It is used to treat migraine disorders in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 1B and 5-hydroxytryptamine receptor 1D. In addition, it is known to target 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 1F, and 5-hydroxytryptamine receptor 1A.

 

Trade Name

 

Amerge
 

Common Name

 

naratriptan
 

ChEMBL ID

 

CHEMBL1278
 

Indication

 

migraine disorders
 

Drug Class

 

Antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives

Image (chem structure or protein)

Naratriptan structure rendering